Header Logo

Connection

LAURA PETERSEN to Factor Xa Inhibitors

Back to Details
This is a "connection" page, showing publications LAURA PETERSEN has written about Factor Xa Inhibitors.
LAURA PETERSEN
Connection Strength
0.160
Factor Xa Inhibitors
  1. Eligibility for Low-Dose Rivaroxaban Based on the COMPASS Trial: Insights from the Veterans Affairs Healthcare System. Cardiovasc Drugs Ther. 2021 06; 35(3):533-538.
    View in: PubMed
    Score: 0.160
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.